a 23 year old female patient come in opd with this and now facing shivering while pcm 1 g is already given to the patient what was the best possible treatment for the patient
| Parameter | Patient Result | Reference Range | Status |
|---|---|---|---|
| WBC | 2.8 × 10⁹/L | 4.0-10.0 | LOW (Leukopenia) |
| RBC | 2.51 × 10¹²/L | 3.50-5.50 | Low |
| HGB | 8.4 g/dL | 11.0-16.0 | LOW (Anaemia) |
| HCT | 26.9% | 37.0-48.0 | Low |
| MCV | 107.1 fL | 82.0-95.0 | HIGH (Macrocytosis) |
| PLT | 41 × 10⁹/L | 150-450 | CRITICALLY LOW (Thrombocytopenia) |
| RDW-CV | 22.9% | 11.5-14.5 | HIGH |
Note: The anaemia with macrocytosis (MCV 107.1) and high RDW suggests a co-existing nutritional deficiency (B12/folate), which should be addressed separately after the acute illness.
IMMEDIATE:
✓ Tepid sponging NOW
✓ IV access + IV fluids (NS/RL)
✓ Admit to ward
ANTIPYRETICS:
✓ PCM 1g every 6 hours PRN (already given - wait 6 hrs)
✗ NO NSAIDs, NO aspirin
MONITORING (every 6-8 hours):
✓ Vitals, urine output
✓ Serial haematocrit + platelets
✓ Watch for warning signs
INVESTIGATIONS:
✓ NS1 antigen, dengue serology
✓ LFT, RFT, electrolytes, malaria smear
Sources: Rosen's Emergency Medicine (p. 2630); Park's Textbook of Preventive and Social Medicine (pp. 295-296); Harrison's Principles of Internal Medicine 22E
can we give hydrocourt to thrombocytopenia patient
corticosteroids dengue thrombocytopenia treatment
corticosteroids dengue fever
"The evidence from trials using corticosteroids in dengue is inconclusive and the quality of evidence is low to very low... There is insufficient evidence to evaluate the effects of corticosteroids in the treatment of early stage dengue fever and dengue-related shock outside of the context of a randomized controlled trial."
| Cause of Thrombocytopenia | Steroids? | Drug of Choice |
|---|---|---|
| ITP (Immune Thrombocytopenic Purpura) | YES - First Line | Prednisolone 1 mg/kg/day (NOT hydrocortisone) |
| Dengue fever | NO - Not recommended | Supportive care + IV fluids |
| TTP (Thrombotic Thrombocytopenic Purpura) | Adjunctive only | Plasma exchange is the primary treatment |
| Aplastic anemia | Sometimes | Depends on cause/severity |
| Drug-induced thrombocytopenia | Occasionally | Remove offending drug first |
| Chemotherapy-induced | NO | Platelet transfusion if < 10,000 or bleeding |
| Sepsis-induced | Only for refractory septic shock (not for platelets) | Treat infection |
"First-line treatment consists of steroids, followed by IVIg, IV anti-D in Rh-positive patients, cytotoxic therapy, or newer thrombopoietin agonists."
Sources: Rosen's Emergency Medicine; Henry's Clinical Diagnosis and Management by Laboratory Methods; Cochrane Review PMID 24984082